A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019)

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

Journal article (2020)

Authors

Sven J. van der Lee Vrije Universiteit Amsterdam
Erik B. van den Akker Pattern Recognition and Bioinformatics - EEMCS , Molecular Epidemiology, Leiden University Medical Center
Najada Stringa Amsterdam UMC
M. Hulsman Vrije Universiteit Amsterdam, Pattern Recognition and Bioinformatics - EEMCS
Niccoló Tesi Pattern Recognition and Bioinformatics - EEMCS , Vrije Universiteit Amsterdam
Marcel Reinders Delft Bioinformatics Lab, Pattern Recognition and Bioinformatics - EEMCS
More Authors... External organisation
Research Group
Pattern Recognition and Bioinformatics (EEMCS) (TU Delft)
More Info
expand_more

Published Date

2020

Language

English

Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Faculty

Electrical Engineering, Mathematics and Computer Science

Department

Intelligent Systems

Research Group

Pattern Recognition and Bioinformatics

Abstract

The IPDGC (The International Parkinson Disease Genomics Consortium) and EADB (Alzheimer Disease European DNA biobank) are listed correctly as an author to the article, however, they were incorrectly listed more than once.

Files

Lee2020_Article_CorrectionToAN... (pdf)
(pdf | 0.492 Mb)
Unknown license

Download not available